(Q39998443)

16 September 2017

title

Maspin reduces prostate cancer metastasis to bone (English)

1 reference

16 September 2017

1 reference

1 reference

Devon C Hall

1

1 reference

16 September 2017

Teresa L Johnson-Pais

2

1 reference

16 September 2017

Barry Grubbs

3

1 reference

16 September 2017

Rosie Bernal

4

1 reference

16 September 2017

Robin J Leach

5

1 reference

16 September 2017

Susan S Padalecki

6

1 reference

16 September 2017

publication date

15 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

652-658

1 reference

RNA Genetics of Breast Cancer: Maspin as Paradigm

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Role of Maspin in Tumor Metastasis and Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Maspin is up-regulated in premalignant prostate epithelia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Maspin is an angiogenesis inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

An efficient method for high-fidelity BAC/PAC retrofitting with a selectable marker for mammalian cell transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Chromosome 18 suppresses prostate cancer metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.07.017

10.1016/J.UROLONC.2007.07.017

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference